AI assistant
Alkem Laboratories Limited — M&A Activity 2021
Apr 6, 2021
61611_rns_2021-04-06_17d74352-49e5-45e0-b286-f2fa83d2c91c.pdf
M&A Activity
Open in viewerOpens in your device viewer
==> picture [596 x 136] intentionally omitted <==
Date: 06[th] April, 2021
To To National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Plot No. C-1, Market Operations Department, Block G, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra East, Mumbai – 400051 Dalal Street, Mumbai – 400001 Scrip Code – 539523 Scrip Symbol – ALKEM
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sirs,
We refer to our disclosure, dated 01[st] April, 2021, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 informing interalia that DigiHealth Technologies LLP, (the wholly owned entity of our investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP)), has agreed to acquire 100% ownership interest in Pharmarack Technologies Private Limited (‘Pharmarack’) in tranches.
Further to the above, we wish to inform you that the above-referred entity, DigiHealth Technologies LLP has completed on 05[th] April, 2021 the acquisition of 91.8% of shareholding in Pharmarack by purchase of shares from multiple shareholders in various lots.
This is for your information and dissemination.
Yours faithfully,
For Alkem Laboratories Limited
Manish Digitally signed by Manish Narang Date: 2021.04.06 Narang 20:01:13 +05'30' __________________________
Manish Narang President – Legal, Company Secretary & Compliance Officer